Eastern tradition · Chinese tonic herb
A Yunnan 'immortality herb' reputed to nourish yin, strengthen qi and benefit the kidneys — modern data suggests anti-aging, blood sugar, and immune effects.
↑ iHerb link is an affiliate link — we may earn a commission at no cost to you.
Huangjing (黄精) appears in the Shennong Bencao Jing (Divine Farmer's Classic, ~200 CE) as a superior tonic that could confer longevity when consumed for years. In Yunnan, steamed-and-dried nine-times Jiuzheng Huangjing is a valued delicacy eaten like a sweet root.
Key active: Polygonatum polysaccharides, steroidal saponins.
Polygonatum polysaccharides activate AMPK and Nrf2 pathways, show anti-glycation and immunomodulatory effects in cell studies. Human trial data is limited but growing — highest-quality evidence is in blood glucose reduction in type 2 diabetics.
Effect summary
| Health outcome | Effect | Magnitude | Grade |
|---|---|---|---|
| Fasting blood glucose (type 2 diabetes) | Decreases | Moderate | B |
| Triglycerides | Decreases | Minor | C |
| Immune function markers | Increases | Minor | C |
| Antioxidant markers | Increases | Minor | C |
| Fatigue — Traditional indication; minimal clinical trial data | Decreases | Minor | D |
Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data
Dosage guidance
The 'nine-steamed, nine-dried' (九蒸九晒) process reduces the saponins that cause throat irritation in raw root, and concentrates the polysaccharides. Yunnan Polygonatum kingianum is a distinct species with similar but distinct phytochemistry from P. sibiricum.
Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.
Evidence summary
Limited human trials; strong preclinical; traditional use thousands of years
Polygonatum polysaccharides activate AMPK and Nrf2 pathways, show anti-glycation and immunomodulatory effects in cell studies. Human trial data is limited but growing — highest-quality evidence is in blood glucose reduction in type 2 diabetics.
According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-06-14. They include trials across many endpoints, not only longevity.
Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.
Evidence collections
Compare the evidence
Suppliers
Tell us what you need and we will source suppliers for you.